Dymista

Product manufactured by Meda Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA202236 None Nasal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Dymista Contains An H 1 -Receptor Antagonist And A Corticosteroid, And Is Indicated For The Relief Of Symptoms Of Seasonal Allergic Rhinitis In Patients 6 Years Of Age And Older Who Require Treatment With Both Azelastine Hydrochloride And Fluticasone Propionate For Symptomatic Relief. ( 1.1 ) 1.1 Seasonal Allergic Rhinitis Dymista Nasal Spray Is Indicated For The Relief Of Symptoms Of Seasonal Allergic Rhinitis In Patients 6 Years Of Age And Older Who Require Treatment With Both Azelastine Hydrochloride And Fluticasone Propionate For Symptomatic Relief.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments